537 related articles for article (PubMed ID: 33266235)
1. Bile Acids and GPBAR-1: Dynamic Interaction Involving Genes, Environment and Gut Microbiome.
Portincasa P; Di Ciaula A; Garruti G; Vacca M; De Angelis M; Wang DQ
Nutrients; 2020 Nov; 12(12):. PubMed ID: 33266235
[TBL] [Abstract][Full Text] [Related]
2. Bile acids and their receptors during liver regeneration: "Dangerous protectors".
Merlen G; Ursic-Bedoya J; Jourdainne V; Kahale N; Glenisson M; Doignon I; Rainteau D; Tordjmann T
Mol Aspects Med; 2017 Aug; 56():25-33. PubMed ID: 28302491
[TBL] [Abstract][Full Text] [Related]
3. Hepatoprotective impact of the bile acid receptor TGR5.
Merlen G; Bidault-Jourdainne V; Kahale N; Glenisson M; Ursic-Bedoya J; Doignon I; Garcin I; Humbert L; Rainteau D; Tordjmann T
Liver Int; 2020 May; 40(5):1005-1015. PubMed ID: 32145703
[TBL] [Abstract][Full Text] [Related]
4. Bile acids as regulators of hepatic lipid and glucose metabolism.
Trauner M; Claudel T; Fickert P; Moustafa T; Wagner M
Dig Dis; 2010; 28(1):220-4. PubMed ID: 20460915
[TBL] [Abstract][Full Text] [Related]
5. Recent Advances in the Digestive, Metabolic and Therapeutic Effects of Farnesoid X Receptor and Fibroblast Growth Factor 19: From Cholesterol to Bile Acid Signaling.
Di Ciaula A; Bonfrate L; Baj J; Khalil M; Garruti G; Stellaard F; Wang HH; Wang DQ; Portincasa P
Nutrients; 2022 Nov; 14(23):. PubMed ID: 36500979
[TBL] [Abstract][Full Text] [Related]
6. The interaction of bile acids and gut inflammation influences the pathogenesis of inflammatory bowel disease.
Di Ciaula A; Bonfrate L; Khalil M; Portincasa P
Intern Emerg Med; 2023 Nov; 18(8):2181-2197. PubMed ID: 37515676
[TBL] [Abstract][Full Text] [Related]
7. Bile Acid Physiology.
Di Ciaula A; Garruti G; Lunardi Baccetto R; Molina-Molina E; Bonfrate L; Wang DQ; Portincasa P
Ann Hepatol; 2017 Nov; 16(Suppl. 1: s3-105.):s4-s14. PubMed ID: 29080336
[TBL] [Abstract][Full Text] [Related]
8. Bile acids and their receptors.
Martinot E; Sèdes L; Baptissart M; Lobaccaro JM; Caira F; Beaudoin C; Volle DH
Mol Aspects Med; 2017 Aug; 56():2-9. PubMed ID: 28153453
[TBL] [Abstract][Full Text] [Related]
9. Bile acid receptors in the biliary tree: TGR5 in physiology and disease.
Deutschmann K; Reich M; Klindt C; Dröge C; Spomer L; Häussinger D; Keitel V
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1319-1325. PubMed ID: 28844960
[TBL] [Abstract][Full Text] [Related]
10. Hepatic Bile Acid Reuptake in the Rat Depends on Bile Acid Conjugation but Not on Agonistic Properties towards FXR and TGR5.
Trammell SAJ; Svenningsen JS; Holst JJ; Gillum MP; Kuhre RE
Molecules; 2020 May; 25(10):. PubMed ID: 32443832
[TBL] [Abstract][Full Text] [Related]
11. Digestive physiology of the pig symposium: intestinal bile acid sensing is linked to key endocrine and metabolic signaling pathways.
Burrin D; Stoll B; Moore D
J Anim Sci; 2013 May; 91(5):1991-2000. PubMed ID: 23729782
[TBL] [Abstract][Full Text] [Related]
12. Gut microbiota-bile acid-intestinal Farnesoid X receptor signaling axis orchestrates cadmium-induced liver injury.
Liu Y; Kang W; Liu S; Li J; Liu J; Chen X; Gan F; Huang K
Sci Total Environ; 2022 Nov; 849():157861. PubMed ID: 35934034
[TBL] [Abstract][Full Text] [Related]
13. The receptor TGR5 protects the liver from bile acid overload during liver regeneration in mice.
Péan N; Doignon I; Garcin I; Besnard A; Julien B; Liu B; Branchereau S; Spraul A; Guettier C; Humbert L; Schoonjans K; Rainteau D; Tordjmann T
Hepatology; 2013 Oct; 58(4):1451-60. PubMed ID: 23686672
[TBL] [Abstract][Full Text] [Related]
14. Interactions between gut bacteria and bile in health and disease.
Long SL; Gahan CGM; Joyce SA
Mol Aspects Med; 2017 Aug; 56():54-65. PubMed ID: 28602676
[TBL] [Abstract][Full Text] [Related]
15. Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism.
Pathak P; Xie C; Nichols RG; Ferrell JM; Boehme S; Krausz KW; Patterson AD; Gonzalez FJ; Chiang JYL
Hepatology; 2018 Oct; 68(4):1574-1588. PubMed ID: 29486523
[TBL] [Abstract][Full Text] [Related]
16. Probiotic Lactobacillus rhamnosus GG Prevents Liver Fibrosis Through Inhibiting Hepatic Bile Acid Synthesis and Enhancing Bile Acid Excretion in Mice.
Liu Y; Chen K; Li F; Gu Z; Liu Q; He L; Shao T; Song Q; Zhu F; Zhang L; Jiang M; Zhou Y; Barve S; Zhang X; McClain CJ; Feng W
Hepatology; 2020 Jun; 71(6):2050-2066. PubMed ID: 31571251
[TBL] [Abstract][Full Text] [Related]
17. The role of farnesoid X receptor in metabolic diseases, and gastrointestinal and liver cancer.
Sun L; Cai J; Gonzalez FJ
Nat Rev Gastroenterol Hepatol; 2021 May; 18(5):335-347. PubMed ID: 33568795
[TBL] [Abstract][Full Text] [Related]
18. Bile acid signaling through farnesoid X and TGR5 receptors in hepatobiliary and intestinal diseases.
Stanimirov B; Stankov K; Mikov M
Hepatobiliary Pancreat Dis Int; 2015 Feb; 14(1):18-33. PubMed ID: 25655287
[TBL] [Abstract][Full Text] [Related]
19. TGR5 signaling mitigates parenteral nutrition-associated liver disease.
Willis KA; Gomes CK; Rao P; Micic D; Moran ER; Stephenson E; Puchowicz M; Al Abdallah Q; Mims TS; Gosain A; Yin D; Talati AJ; Chang EB; Han JC; Pierre JF
Am J Physiol Gastrointest Liver Physiol; 2020 Feb; 318(2):G322-G335. PubMed ID: 31905022
[TBL] [Abstract][Full Text] [Related]
20. Prevention of spontaneous hepatocarcinogenesis in farnesoid X receptor-null mice by intestinal-specific farnesoid X receptor reactivation.
Degirolamo C; Modica S; Vacca M; Di Tullio G; Morgano A; D'Orazio A; Kannisto K; Parini P; Moschetta A
Hepatology; 2015 Jan; 61(1):161-70. PubMed ID: 24954587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]